MYC as a regulator of ribosome biogenesis and protein synthesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
MYC regulates the transcription of thousands of genes required to coordinate a range of cellular processes, including those essential for proliferation, growth, differentiation, apoptosis and self-renewal. Recently, MYC has also been shown to serve as a direct regulator of ribosome biogenesis. MYC coordinates protein synthesis through the transcriptional control of RNA and protein components of ribosomes, and of gene products required for the processing of ribosomal RNA, the nuclear export of ribosomal subunits and the initiation of mRNA translation. We discuss how the modulation of ribosome biogenesis by MYC may be essential to its physiological functions as well as its pathological role in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanical loading is also conveyed to the nucleolus through the transcription factor c-Myc”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“without sufficient induction of c-Myc, the expansion of translational capacity may be limited despite favorable metabolic conditions”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“Because this 45S transcript is rapidly processed and possesses a half-life measured in minutes, its abundance serves as an ultrasensitive, real-time indicator of active Pol I initiation and nucleolar stress [30,58].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · cited 1×
“The deregulated expression of Myc proteins has been implicated in the development of a wide range of cancers (reviewed in Ref”
BackgroundTranscriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Molecular mechanisms of translational control
Gebauer, F., & Hentze, M. W. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1488 · Cited by 991 · cited 1×
“The translational machinery is composed of ribosome subunits, mRNA, transfer RNAs (tRNAs), and translation initiation and elongation factors (reviewed in Ref”
BackgroundGenomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Cited by
Items 401–500 of 967
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma
Yao, Y., Ng, J. F., Park, W. D., Samur, M., Morelli, E., Encinas, J., Chyra, Z., Xu, Y., Derebail, S., Epstein, C. B., et al. (2023) · Blood · doi:10.1182/blood.2022018885 · Cited by 42
Chen, Y., Li, Y., Dai, R. S., Savage, J. C., Shinde, U. P., Klimek, J. E., David, L. L., Young, E. A., Hafner, M., Sears, R. C., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad140 · Cited by 25
Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis
Madala, S. K., Edukulla, R., Phatak, M., Schmidt, S., Davidson, C. R., Acciani, T. H., Korfhagen, T. R., Medvedovic, M., Cras, T. D. L., Wagner, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086536 · Cited by 28
Dungwa, J. V., Hunt, L. P., & Ramani, P. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.006 · Cited by 25
Meng, X., Carlson, N. R., Dong, J., & Zhang, Y. (2015) · Oncogene · doi:10.1038/onc.2015.39 · Cited by 25
Transcriptional Networks Controlling the Cell Cycle
Bonke, M., Turunen, M. M., Sokolova, M., Vähärautio, A., Kivioja, T., Taipale, M., Björklund, M., & Taipale, J. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.004283 · Cited by 30
Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis
Carter, D. R., Sutton, S. K., Pajic, M., Murray, J. E., Sekyere, E. O., Fletcher, J. I., Beckers, A., Preter, K. D., Speleman, F., George, R. E., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.02.004 · Cited by 29
Korkmaz, S., & Korkmaz, H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15185 · Cited by 26
Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors
Shannon, M. L., Fame, R. M., Chau, K. F., Dani, N., Calicchio, M. L., Géléoc, G. S. G., Lidov, H. G. W., Alexandrescu, S., & Lehtinen, M. K. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.02.009 · Cited by 25
Zhou, Z., Ai, H., Li, K., Yao, X., Zhu, W., Liu, L., Yu, C., Song, Z., Bao, Y., Huang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19917-7 · Cited by 25
Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
Wu, C. L., Yang, P., Liu, B., & Tang, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232464 · Cited by 33
LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancy
Missios, P., da Rocha, E. L., Pearson, D. S., Philipp, J., Aleman, M. M., Pirouz, M., Farache, D., Franses, J. W., Kubaczka, C., Tsanov, K. M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145142 · Cited by 26
Myc controls NK cell development, IL-15-driven expansion, and translational machinery
Khameneh, H. J., Fonta, N., Zenobi, A., Niogret, C., Ventura, P., Guerra, C., Kwee, I., Rinaldi, A., Pecoraro, M., Geiger, R., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302069 · Cited by 32
Dong, M., Wang, X., Zhao, H., Chen, X., Yuan, J., Guo, J.-Y., Li, K.-Q., & Li, G. (2015) · Europe PMC (PubMed Central) · Cited by 24
Ciribilli, Y., Singh, P., Inga, A., & Borlak, J. T. (2016) · Oncotarget · doi:10.18632/oncotarget.11804 · Cited by 25
Translational control by mTOR-independent routes: how eIF6 organizes metabolism
Miluzio, A., Ricciardi, S., Manfrini, N., Alfieri, R. R., Oliveto, S., Brina, D., & Biffo, S. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160179 · Cited by 23
MYC and AMPK–Save Energy or Die!
Haikala, H. M., Anttila, J. M., & Klefström, J. T. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00038 · Cited by 33
MYC modulators in cancer: a patent review
Wang, X., Su, X., Cheng, S.-Q., Zhi-yin, S., Huang, Z., & Ou, T. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1612878 · Cited by 28
Impaired Ribosomal Biogenesis by Noncanonical Degradation of β -Catenin during Hyperammonemia
Davuluri, G., Giusto, M., Chandel, R., Welch, N., Alsabbagh, K., Kant, S., Kumar, A., Kim, A., Gangadhariah, M. H., Ghosh, P. K., et al. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00451-18 · Cited by 24
Freeman, B. T., Jung, J. P., & Ogle, B. M. (2016) · Scientific Reports · doi:10.1038/srep23270 · Cited by 24
Valdés, A., García‐Cañas, V., Pérez-Sánchez, A., Barrajón‐Catalán, E., Ruiz-Torres, V., Artemenko, K. A., Micol, V., Bergquist, J., & Cifuentes, A. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.03.072 · Cited by 26
Visualizing the nucleoplasmic maturation of human pre-60S ribosomal particles
Zhang, Y., Liang, X., Luo, S., Chen, Y., Li, Y., Ma, C., Li, N., & Gao, N. (2023) · Cell Research · doi:10.1038/s41422-023-00853-9 · Cited by 22
The yeast Hot1 transcription factor is critical for activating a single target gene,STL1
Bai, C. G., Tesker, M., & Engelberg, D. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-12-1626 · Cited by 22
Derenzini, M., Montanaro, L., & Treré, D. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36627 · Cited by 23
Deciphering c-MYC-regulated genes in two distinct tissues
Robson, S. C., Ward, L., Brown, H. K., Turner, H., Hunter, E., Pelengaris, S., & Khan, M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-476 · Cited by 23
Young-Baird, S. K., Shao, Y., Bidwell, J. P., & Wek, R. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729830 · Cited by 23
MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis
Lafita‐Navarro, M. C., Blanco, R. E., Mata-Garrido, J., Liaño-Pons, J., Tapia, O., García-Gutiérrez, L., García-Alegría, E., Berciano, M. T., Lafarga, M., & León, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11766 · Cited by 22
Zomerman, W. W., Plasschaert, S. L. A., Conroy, S., Scherpen, F. J. G., Boer, T. M.-D., Lourens, H. J., Llobet, S. G., Smit, M. J., Slagter‐Menkema, L., Seitz, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.089 · Cited by 22
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Nardi, F., Perurena, N., Schade, A. E., Li, Z.-H., Ngo, K., Ivanova, E. V., Saldanha, A., Li, C., Gokhale, P. C., Hata, A. N., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167651 · Cited by 21
Targeted degradation of CDK9 potently disrupts the MYC-regulated network
Toure, M. A., Motoyama, K., Xiang, Y., Urgiles, J., Kabinger, F., Koglin, A.-S., Iyer, R. S., Gagnon, K., Kumar, A., Ojeda, S., et al. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.03.001 · Cited by 24
Jaiswal, A. K., Truong, H., Tran, T. M., Lin, T. L., Casero, D., Alberti, M. O., & Rao, D. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-92448-w · Cited by 25
Mapping the invisible chromatin transactions of prophase chromosome remodeling
Samejima, I., Spanos, C., Samejima, K., Rappsilber, J., Kustatscher, G., & Earnshaw, W. C. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.039 · Cited by 21
Regulation of Nucleolar Activity by MYC
Brown, I. N., Lafita‐Navarro, M. C., & Conacci‐Sorrell, M. (2022) · Cells · doi:10.3390/cells11030574 · Cited by 23
Dönig, J., Mende, H., Gallesio, J. D., Wagner, K., Hotz, P. W., Schunck, K., Piller, T., Hölper, S., Uhan, S., Kaulich, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43751-9 · Cited by 25
Genomic regression analysis of coordinated expression
Cai, L., Li, Q., Du, Y., Yun, J., Xie, Y., DeBerardinis, R. J., & Xiao, G. (2017) · Nature Communications · doi:10.1038/s41467-017-02181-0 · Cited by 24
Chakraborty, A., Uechi, T., Nakajima, Y., Gazda, H. T., O’Donohue, M.-F., Gleizes, P., & Kenmochi, N. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.019 · Cited by 21
Zhang, Z., Shi, L., Song, L., Maurer, K., Petri, M. A., & Sullivan, K. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00497 · Cited by 21
Guo, Y., Sun, H., Wang, X., & Wang, M. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1700319 · Cited by 20
Transcriptional versus metabolic control of cell fitness during cell competition
Lawlor, K., Pérez-Montero, S., Lima, A., & Rodríguez, T. A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.010 · Cited by 23
WD40 protein Wuho controls germline homeostasis via TRIM-NHL tumor suppressor Mei-p26 in Drosophila
Rastegari, E., Kajal, K., Tan, B. S., Huang, F., Chen, R., Hsieh, T.-S., & Hsu, H. (2020) · Development · doi:10.1242/dev.182063 · Cited by 20
Hu, M., Zhang, Y., Gu, D., Chen, X., Waldor, M. K., & Zhou, X. (2020) · The EMBO Journal · doi:10.15252/embj.2020105699 · Cited by 21
Emerging therapies for inv(16) AML
Surapally, S., Tenen, D. G., & Pulikkan, J. A. (2021) · Blood · doi:10.1182/blood.2020009933 · Cited by 25
Lin, C., Lai, G., Chen, K., Lin, T.-H., Fan, J.-J., Hsu, R.-L., Chou, C., Lin, C., Kandaswami, C. C., Lee, M., et al. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.09.030 · Cited by 21
Sadeghifar, F., Böhm, S., Vintermist, A., & Farrants, A. Ö. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv312 · Cited by 23
BET inhibitors reduce cell size and induce reversible cell cycle arrest in AML
Zhang, S., Zhao, Y., Heaster, T. M., Fischer, M. A., Stengel, K. R., Zhou, X., Ramsey, H. E., Zhou, M., Savona, M. R., Skala, M. C., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28005 · Cited by 21
WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think
Weissmiller, A. M., Fesik, S. W., & Tansey, W. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13010274 · Cited by 19
Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression
Gan, Y., Hao, Q., Han, T., Tong, J., Yan, Q., Zhong, H., Gao, B., Li, Y., Xuan, Z., Li, P., et al. (2024) · Advanced Science · doi:10.1002/advs.202407370 · Cited by 26
Chaturvedi, N. K., Kling, M. J., Griggs, C. N., Kesherwani, V., Shukla, M., McIntyre, E. M., Ray, S., Liu, Y., McGuire, T. R., Sharp, J. G., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0996 · Cited by 21
Tegtmeyer, B., Vièyres, G., Tödt, D., Lauber, C., Ginkel, C., Engelmann, M., Herrmann, M., Pfaller, C. K., Vondran, F. W. R., Broering, R., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00245-21 · Cited by 22
Cell competition from development to neurodegeneration
RODRIGUES, M. C., Couceiro, J., & Moreno, E. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048926 · Cited by 24
Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia
Wang, H., Lu, J. L., Alencastro, F., Roberts, A., Fiedor, J., Carroll, P. A., Eisenman, R. N., Ranganathan, S., Torbenson, M. S., Duncan, A. W., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.018 · Cited by 19
RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
Shi, R., & Liu, Z. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02555-5 · Cited by 20
Kotkamp, K., Kur, E., Wendik, B., Polok, B., Ben‐Dor, S., Onichtchouk, D., & Driever, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092356 · Cited by 22
Hovhanyan, A., Herter, E. K., Pfannstiel, J., Gallant, P., & Raabe, T. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00658-13 · Cited by 29
Mouse modelling of the MDM2/MDMX−p53 signalling axis
Tackmann, N. R., & Zhang, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx006 · Cited by 23
Deciphering GRINA/Lifeguard1: Nuclear Location, Ca2+ Homeostasis and Vesicle Transport
Jiménez-González, V., Ogalla, E., García‐Quintanilla, M., & García-Quintanilla, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164005 · Cited by 21
Suginohara, T., Wakabayashi, K., Ato, S., & Ogasawara, R. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154419 · Cited by 23
Lewińska, A., Klukowska‐Rötzler, J., Deręgowska, A., Adamczyk‐Grochala, J., & Wnuk, M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101163 · Cited by 20
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity
Copland, A., Mackie, G. M., Scarfe, L., Jinks, E., Lecky, D. A. J., Gudgeon, N. H., McQuade, R., Lab), M. O. (., Barthel, M., Hardt, W., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00159-2 · Cited by 26
Dong, Z., Li, J., Dai, W., Yu, D., Zhao, Y., Liu, S., Li, X., Zhang, Z., Zhang, R., Liang, X., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05578-6 · Cited by 22
Ozoe, A., Sone, M., Fukushima, T., Kataoka, N., Chida, K., Asano, T., Hakuno, F., & Takahashi, S. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00024 · Cited by 23
Strilbytska, O. M., Semaniuk, U. V., Storey, K. B., Edgar, B. A., & Lushchak, O. V. (2016) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2016.09.008 · Cited by 20
Notch pathway: a bistable inducer of biological noise?
Vujovic, F., Hunter, N., & Farahani, R. H. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0453-0 · Cited by 18
NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p
Dong, D., Song, M. L., Wu, X., & Wang, W. (2020) · Cytotechnology · doi:10.1007/s10616-020-00394-8 · Cited by 19
Ribosomes: An Exciting Avenue in Stem Cell Research
Han, Z., Zhang, Q., Zhu, Y., Chen, J., & Li, W. (2020) · Stem Cells International · doi:10.1155/2020/8863539 · Cited by 21
Witte, K. E., Hertel, O., Windmöller, B. A., Helweg, L. P., Höving, A. L., Knabbe, C., Busche, T., Greiner, J. F. W., Kalinowski, J., Noll, T., et al. (2021) · Cancers · doi:10.3390/cancers13051136 · Cited by 19
Windmöller, B. A., Beshay, M., Helweg, L. P., Flottmann, C., Beermann, M., Förster, C., Wilkens, L., Greiner, J. F. W., Kaltschmidt, C., & Kaltschmidt, B. (2021) · Cells · doi:10.3390/cells10051024 · Cited by 19
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
Kling, M. J., Griggs, C. N., McIntyre, E. M., Alexander, G. R., Ray, S., Challagundla, K. B., Joshi, S. S., Coulter, D. W., & Chaturvedi, N. K. (2021) · BMC Cancer · doi:10.1186/s12885-021-08782-9 · Cited by 21
Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice
Jenkins, N., Rao, G., Eberhart, C. G., Pedone, C. A., Dubuc, A. M., & Fults, D. W. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1985-9 · Cited by 22
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc
Nagasaka, M., Tsuzuki, K., Ozeki, Y., Tokugawa, M., Ohoka, N., Inoue, Y., & Hayashi, H. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00892 · Cited by 19
Cell competition in vertebrate organ size regulation
Penzo‐Méndez, A., & Stanger, B. Z. (2014) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.148 · Cited by 22
Vito, A. D., Lazzaro, M., Palmisano, I., Cittaro, D., Riba, M., Lazarevic, D., Bannai, M., Gabellini, D., & Schiaffino, M. V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200783 · Cited by 16
Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer
Nakamura, K., Reid, B. M., Chen, A., Chen, Z., Goode, E. L., Permuth, J. B., Teer, J. K., Tyrer, J. P., Yu, X., Kanetsky, P. A., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.020 · Cited by 18
RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
Li, H., Gao, L., Kang, X., Wang, X., Yu, Y., Yaqing, Z., & Chen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010806 · Cited by 18
The Effects of Deregulated Ribosomal Biogenesis in Cancer
Lu, Y., Wang, S., & Jiao, Y. (2023) · Biomolecules · doi:10.3390/biom13111593 · Cited by 20
Vicente, J. J., Khan, K., Tillinghast, G., McFaline‐Figueroa, J. L., Sancak, Y., & Stella, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05234-3 · Cited by 21
The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond
Niu, M.-Y., Liu, Y.-J., Shi, J., Chen, R.-Y., Zhang, S., Li, C.-Y., Cao, J.-F., Yang, G., & Chen, J. (2024) · Biomolecules · doi:10.3390/biom14050572 · Cited by 22
Marinho, J. C. L., Martins, T., Neto, M., Casares, F., & Pereira, P. S. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.02.003 · Cited by 20
Targeting RNA Polymerase I with Hernandonine Inhibits Ribosomal RNA Synthesis and Tumor Cell Growth
Chen, Y., Chen, J., & Wang, H. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0402 · Cited by 18
Dai, H., Yan, M., & Li, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.163 · Cited by 18
Basta, J. M., Singh, A. P., Robbins, L., Stout, L., Pherson, M., & Rauchman, M. I. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.05.008 · Cited by 18
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer
Elsharawy, K. A., Althobiti, M. M., Mohammed, O. J., Aljohani, A., Toss, M. S., Green, A. R., & Rakha, E. A. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05999-3 · Cited by 20
Translation initiation and its relevance in colorectal cancer
Minnee, E., & Faller, W. J. (2020) · FEBS Journal · doi:10.1111/febs.15690 · Cited by 21
Suseela, Y. V., Sengupta, P., Roychowdhury, T., Panda, S., Talukdar, S., Chattopadhyay, S., Chatterjee, S., & Govindaraju, T. (2021) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.1c00039 · Cited by 20
Xia, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i8.2433 · Cited by 18
Kim, H. J., Osteil, P., Humphrey, S. J., Cinghu, S., Oldfield, A., Patrick, E., Wilkie, E. E., Peng, G., Suo, S., Jothi, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1179 · Cited by 18
de Magalhães, C. R., Sandoval, K., Kagan, F., McCormack, G. P., Schrama, D., Carrilho, R., Farinha, A. P., Cerqueira, M. A. C., & Rodrigues, P. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300472 · Cited by 20
Resistance exercise increases intramuscular NF-κb signaling in untrained males
Townsend, J. R., Stout, J. R., Jajtner, A. R., Church, D. D., Beyer, K. S., Oliveira, L., Monica, M. B. L., Riffe, J. J., Muddle, T. W. D., Baker, K. M., et al. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3463-2 · Cited by 18
Mathison, A., Kerketta, R., de Assuncao, T. M., Leverence, E. N., Zeighami, A., Urrutia, G., Stodola, T. J., di Magliano, M. P., Iovanna, J., Zimmermann, M. T., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02498-6 · Cited by 18
Dörner, K., Badertscher, L., Horváth, B., Hollandi, R., Molnár, C., Fuhrer, T., Meier, R., Sárazová, M., van den Heuvel, J., Zamboni, N., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac072 · Cited by 18
Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis
Johnson, T. A., Maekawa, S., Fujita, M., An, J., Ju, Y.-S., Maejima, K., Kanazashi, Y., Jikuya, R., Okawa, Y., Sasagawa, S., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac180 · Cited by 17
Constable, S., Ott, C. M., Lemire, A. L., White, K., Xun, Y., Lim, A., Lippincott‐Schwartz, J., & Mukhopadhyay, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408083121 · Cited by 17
Smekalova, E. M., Gerashchenko, M. V., O’Connor, P. B. F., Whittaker, C. A., Kauffman, K. J., Fefilova, A. S., Zatsepin, T. S., Bogorad, R. L., Baranov, P. V., Langer, R., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.009 · Cited by 20
Targeting cancer via ribosome biogenesis: the cachexia perspective
Figueiredo, V. C., & McCarthy, J. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03888-6 · Cited by 20
Bai, M., Cui, M., Li, M., Yao, X., Wu, Y., Zheng, L., Sun, L., Song, Q., Wang, S., Liu, L., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62339 · Cited by 18
Targeting G-Quadruplex DNA for Cancer Chemotherapy
Acharya, P. C., & Debbarma, S. (2022) · Current Drug Discovery Technologies · doi:10.2174/1570163819666220214115408 · Cited by 19
Dungwa, J. V., Hunt, L. P., & Ramani, P. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04227.x · Cited by 18
Perina, D., Korolija, M., Hadžija, M. P., Grbeša, I., Belužić, R., Imešek, M., Morrow, C. C., Marjanović, M. P., Bakran‐Petricioli, T., Mikoč, A., et al. (2015) · Marine Drugs · doi:10.3390/md13074179 · Cited by 20
Zhang, P., Tang, L., Gao, H., Zhang, W., Lin, J., & Yang, H. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.08.02 · Cited by 19
Tran, H. M., Wu, K.-S., Sung, S., Changou, C. A., Hsieh, T., Liu, Y., Liu, Y., Tsai, M., Lee, H., Hsieh, K. L., et al. (2020) · Cancers · doi:10.3390/cancers12030752 · Cited by 18
Metadata
- Authors
- van Riggelen, J., Yetil, A., & Felsher, D. W.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Felsher, Dean W.
- ORCID
- Felsher, Dean W.
- Venue
- Nature Reviews Cancer
- Published
- 2010-04
- Volume
- 10
- Issue
- 4
- Pages
- 301-309
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2021764678
- Cited by
- 956
- References
- 126
- Citations by year
- 2026: 59 · 2025: 65 · 2024: 94 · 2023: 72 · 2022: 61 · 2021: 68 · 2020: 75 · 2019: 63 · 2018: 50 · 2017: 57 · 2016: 48 · 2015: 57 · 2014: 53 · 2013: 43 · 2012: 39
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Leukemia and Lymphoma Society
- Canada Research Chairs
- National Institutes of Health
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, ribosome biogenesis, protein synthesis, rRNA processing, translation initiation, transcriptional regulation, carcinogenesis, cell proliferation
- MeSH terms
- Gene Expression Regulation, Homeostasis, Humans, Models, Genetic, Neoplasms, Ribosomal Proteins, Ribosomes, RNA, Messenger, Protein Biosynthesis, Genes, myc, Proto-Oncogene Proteins c-myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.